Lilly’s Orforglipron Bests Farxiga In Type 2 Diabetes Head-to-Head

 
• By Andrew McConaghie
  
Two further Phase III readouts boost the oral GLP-1 ’s claims to be a future ‘foundational’ medicine in type 2 diabetes. (Shutterstock)

More from Clinical Trials

More from R&D